ENTITY
Takeda Pharmaceutical

Takeda Pharmaceutical (4502 JP)

235
Analysis
Health CareJapan
Takeda Pharmaceutical Co Ltd focuses on the Research & Development, Manufacturing, Sales and Marketing and Import/Export of Pharmaceutical Drugs. The Company focuses on the following core therapeutic areas: Cardiovascular & Metabolic, Oncology, Central Nervous System, Respiratory & Immunology, General Medicine (Gastrointestinal & Genitourinary) and Vaccine.
more
16 Dec 2018 07:50

Softbank Corp, Takeda, and Newton's Three Laws of Motion

It has been a huge Q4 for Japan capital markets and banking, and the result is some fat fees for global investment bankers on the Takeda/Shire...

Logo
1.2k Views
Share
16 Dec 2018 07:46

Last Week in Event SPACE: ANTA, Japan Display, Pioneer, Naspers, Huatai, Red Hat

 Last Week in Event SPACE ... The reward/risk is pretty decent on the Anta Sports Products (2020 HK) /Amer Sports Oyj (AMEAS FH) trade. A rumoured...

Logo
533 Views
Share
09 Dec 2018 22:56

Takeda and Shire Shareholders Unanimously Agree to $64b Deal

Our take… Reiterating our positive view, we think the deal could help Takeda on several fronts, including: Sizeable footprint in the strategically...

05 Dec 2018 23:59

Takeda/Shire VI: Now For The Real Fun

At today's AGM, Takeda Pharmaceutical (4502 JP) shareholders approved the agenda items required to approve and complete the Scheme with Shire PLC...

Logo
1.8k Views
Share
28 Nov 2018 16:59

Takeda/Shire V: Tradition vs the Next Generation, Former Chairman Doesn't Support But...

Early this morning, the Nikkei carried an article (English version) saying that former Takeda Pharmaceutical (4502 JP) CEO and Chairman Kunio...

Logo
776 Views
Share
x